	US 12,109,220 B2
	Compositions for use in the reduction of nociception in children
Sami Damak, Lausanne (CH); Norbert Sprenger, Savigny (CH); and Francis Foata, La Conversion (CH)
Assigned to Societe des Produits Nestle S.A., Vevey (CH)
Filed by SOCIETE DES PRODUITS NESTLE S.A., Vevey (CH)
Filed on May 18, 2022, as Appl. No. 17/747,106.
Application 17/747,106 is a continuation of application No. 16/956,723, granted, now 11,357,785, previously published as PCT/EP2018/085862, filed on Dec. 19, 2018.
Claims priority of application No. 17209905 (EP), filed on Dec. 22, 2017.
Prior Publication US 2022/0331347 A1, Oct. 20, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/702 (2006.01); A61K 9/00 (2006.01); A61K 31/7016 (2006.01); A61P 29/00 (2006.01)

CPC A61K 31/702 (2013.01) [A61K 9/0056 (2013.01); A61K 9/0095 (2013.01); A61K 31/7016 (2013.01); A61P 29/00 (2018.01)]

19 Claims

1. A method for reducing nociception in a child in need thereof, the method comprising administering to the child a growing-up milk comprising 6′-sialyllactose (6′SL) and lacto-N-tetraose (LNT), wherein the growing-up milk does not include any fucosylated oligosaccharide.